Objective: Platelet adhesion to areas of endothelial denudation following angioplasty is an important factor contributing to the limitations of this technique. Lipophilic S-nitrosothiols like S-nitroso-N-valerylpenicillamine (SNVP) are novel nitric oxide (NO) donor drugs with anti-platelet and vasodilator properties that are selective for areas of endothelial denudation. Here we assess the inhibitory effect of SNVP on platelet adhesion to angioplastied rabbit carotid arteries. Methods: A rabbit model was used to measure adhesion of radiolabelled platelets to carotid arteries following balloon angioplasty. The effects of SNVP were compared to the conventional NO donor, nitroglycerin (NTG). Electron microscopy was used to visualize adhering platelets. Results: Angioplasty resulted in endothelial denudation with only a modest reduction in vessel contractility. In vivo administration of NTG and SNVP (both 200 nmol) prevented the hyper-aggregability (|20%) of circulating platelets caused by angioplasty. However, bolus NTG failed to inhibit adhesion of radiolabelled platelets 30 min after angioplasty, despite inducing a transient 30% reduction in systemic blood pressure. In contrast, equimolar SNVP had little effect on blood pressure but markedly inhibited platelet adhesion (62% compared to control; P50.003). Platelet adhesion was confirmed with electron microscopy. Conclusion: The prolonged effects of SNVP at sites of endothelial damage suggest that novel S-nitrosothiols might offer a means of targeted delivery of an antiplatelet agent to areas of vascular injury.
nitrosothiols, including S-nitroso-N-valerylpenicillamine
NTG (Schwarz Pharma) or SNVP (both 200 nmol) imme-(SNVP), which have a prolonged vasodilator activity that diately upstream of the angioplastied region ( Fig. 1 ). Both is selective for blood vessels with experimentally denuded SNVP [13] and NTG [16] release 1 molar equivalent of endothelium [13] .
NO. Blood flow over the angioplastied region was restored Using a rabbit model, we tested the hypothesis that and animals were killed 35 min after angioplasty with platelet adhesion to the intimal surface of common carotid pentobarbitone (Genus Express). Both common carotid arteries following angioplasty is inhibited to a greater arteries were dissected free and placed in standard Krebs extent by SNVP than by the conventional nitrate, nitrosolution [13] . Arteries were then cleaned of connective glycerin (NTG).
tissue and divided into rings for further assessment (Fig.  1 ).
. Methods

.2. Preparation and measurement of radiolabelled platelets
All procedures were performed in accordance with the Animals (Scientific Procedures) Act 1986 (UK Home Citrated blood was centrifuged with prostacyclin (300 Office). All chemicals were obtained from Sigma, unless ng / ml; Affiniti Research Products) to obtain pelleted 111 stated otherwise. SNVP was synthesized by a published platelets. Platelets were radiolabelled with InCl 3 method [14] .
(NENீ Life Science Products) and re-suspended in prostacyclin-free solution [17] . The final suspension contained 6 C 2 .1. Surgical procedure |330310 platelets / ml (determined with a Coulter A .T 8 Haematology Analyser, Coulter Electronics). Approxi- 6 Adult male New Zealand white rabbits (2.5-3.5 kg; mately 1 ml platelet suspension (50-300310 platelets; 3 n560) were anesthetised as previously described [15] . The radioactivity550-800310 decays per minute; dpm) was left femoral artery was cannulated (3F) for the measurere-injected into the donor rabbit via a marginal ear vein ment of systemic blood pressure and heart rate (CAPTO |10 min before angioplasty. Radioactivity of blood sam-SP844 transducer, AD Instruments) and 5 ml of blood was ples (100 ml) and segments of carotid artery (|5 mm) was withdrawn into a Monovetteீ tube containing 0.4 ml assessed by a Packard 1900TR liquid scintillation analyser. sodium citrate (3.8%). The external carotid artery was cannulated and a 2.5320 mm angioplasty balloon (Boston 2 .3. Platelet aggregation Scientific SCIMED) was passed into the common carotid artery (Fig. 1) . Angioplasty was performed on a 40-mm
Five ml blood samples were taken from the femoral section of artery, using 2330 s inflations (10 atm, with a artery before angioplasty and immediately before the 15-s interval). The balloon was withdrawn under 4 atm animal was killed. Platelet-rich plasma (PRP; 0.5 ml) was pressure. Sham operations involved cannulation of the pre-warmed to 37 8C for 5 min in a two-channel platelet common carotid artery without balloon inflation. The aggregometer (Cronolog Ca560, Labmedics) [18] . Platelet artery was recannulated to administer a 0.2-ml bolus of aggregation in response to adenosine 59-diphosphate (ADP; heparinised saline (Hep-Sal; 25 U / ml; Genus Express), 8 mmol / l) was measured turbidometrically for a period of Krebs solution at 37 8C. Tension was applied to vessels in stepwise increments to obtain a resting tension of 7 g and allowed to equilibrate for 30-40 min. Rings were contracted (33) to obtain the maximum contraction to high 
.5. Electron microscopy
Segments of carotid artery (3 mm) were fixed in 3% glutaraldehyde and osmium tetroxide, dehydrated in graded acetone and critical point dried with CO . The maximum vasoconstriction to PE (0.1-10 mmol / l; P5 angioplastied arteries was confirmed by immunohisto-1 0.002; n56; Fig. 2b ). Responses to high K Krebs and PE chemistry (results not shown). in sham operated vessels were not different from those in contralateral vessels (P5ns; n57).
.2. Effect of drug bolus on vessel function ex vivo
Following precontraction with PE (2.760.2 mmol / l; n512), ACh (0.01-30 mmol / l) produced a similar degree Bolus administration of either NO donor immediately of concentration-dependent vasodilatation in un-injured after angioplasty in vivo had no significant effect on contralateral arteries and sham vessels, with almost com-1 responses to high K Krebs, PE (EC 50.6-1.5 mmol / l), 50 plete loss of tone at 30 mmol / l ACh (Fig. 3a) . There was ACh (EC 547-120 nmol / l), oxyhemoglobin or L-NAME 50 marked attenuation of the maximum vasodilatation to ACh in either angioplastied or contralateral vessels (P5ns; n5 in angioplastied vessels, from 9062 to 20610% (P, 5-6 for all; results not shown). 0.001; n56).
In the presence of PE (1.360.1 mmol / l; n511), oxyhemoglobin (10 mmol / l) increased tone from 5463 to 3 .3. Effect of drug bolus on blood pressure 1 9265% (n57) of the maximal K Krebs-induced contraction in the contralateral vessels (Fig. 3b) . In the same Before angioplasty, baseline systolic and diastolic blood preconstricted vessels, L-NAME (200 mmol / l) increased pressure was 6164 and 4463 mmHg (n521), respectivevessel tone from 5961 to 7362% (n56; Fig. 3b ). These ly, and heart rate 22069 bpm (n517). Hep-Sal bolus (0.2 responses to oxyhemoglobin and L-NAME were similar in ml) had no effect on blood pressure or heart rate ( Table 1 sham-operated in comparison to contralateral vessels (P5 and Fig. 4 ). NTG bolus (200 nmol) caused a significant ns; n56-7). In angioplastied vessels, oxyhemoglobin and transient reduction in both systolic and diastolic blood L-NAME had no effect on vessel tone (P5ns; n53-5).
pressure, whereas SNVP (200 nmol) had no effect (Table  The removal Following angioplasty with Hep-Sal, there was a carotid arteries following drug treatment (0.2 ml; 200 nmol). Radio-9.362.6 mV increase (|25%) in platelet aggregation to labelled-platelet adhesion is expressed as dpm, standardised to vessel length and whole blood radioactivity. Vessels were isolated and platelet ADP (8 mmol / l) compared to before angioplasty (Table   adhesion measured 1). In contrast, there was no increase in aggregability of ns * P,0.05; ** P,0.01; non significant.. platelets in PRP from rabbits that received NTG or SNVP after angioplasty (Table 1) . compared to contralateral vessels (index50.01360.01 dpm). NTG did not reduce platelet adhesion in angioplas-3 .5. Radiolabelled platelet adhesion to carotid arteries tied vessels, in comparison to Hep-Sal (P5ns; n56 and 7, respectively), whereas SNVP reduced it by 6267% (P5 In angioplastied vessels, there was an almost 20-fold 0.003; n57; Fig. 5 ): and to a greater extent than NTG increase in platelet adhesion (index50.2560.04; Fig. 5 ) (P50.01; n56).
.4. Effect of drug bolus on platelet aggregation
.6. Electron microscopy
Adhesion of platelets to the lumen of blood vessels was confirmed using scanning electron microscopy (Fig. 6) . Following a Hep-Sal bolus, angioplastied vessels showed adhering and activated platelets covering the entire luminal surface (Fig. 6b) . Transmission electron microscopy revealed platelets with pseudopodia extending over the intimal surface and with a loss of cytoplasmic granules, confirming both adhesion and activation (Fig. 6b inset) . In angioplastied vessels treated with SNVP, the number of activated platelets adhering to the luminal surface was substantially reduced (Fig. 6c) .
. Discussion
We have demonstrated that a novel S-nitrosothiol, SNVP, reduces adhesion of radiolabelled platelets to rabbit carotid arteries following angioplasty in vivo, without significantly affecting systemic blood pressure. In contrast, equimolar NTG caused an undesirable decrease (30%) in systemic blood pressure, but failed to inhibit local platelet that the added benefits of SNVP are due to a prolonged antiplatelet action selectively at sites of endothelial cell damages the vascular endothelium, leading to platelet damage.
activation, that is a key event in the initiation of vascular remodelling [5, 20] . Current anti-thrombotic therapies, in-4 .1. Platelet activation and angioplasty cluding aspirin, clopidogrel and GPIIb / IIIa antagonists, have been shown to reduce platelet adhesion and intimal The major limitations of angioplasty are thrombosis and thickening following angioplasty [6] [7] [8] . However, mainrestenosis of treated arteries. The technique inevitably taining sufficiently high local drug concentration over a number of hours can be problematic [2, 21, 22] . Recently, other novel lipophilic S-nitrosothiols produce sustained sirolimus (rapamycin)-eluting stents have been shown to be vasodilatation in human arteries and veins both ex vivo particularly effective at inhibiting neointimal hyperplasia [30] and in vivo [31] , which may potentially be of great [8, 23] , but this approach does not have anti-platelet actions benefit in preventing vasospasm in angioplastied arteries. and the long-term effectiveness (.1 year) has yet to be This evidence strongly suggests that locally-delivered established. Despite current advances in drug delivery SNVP is able to specifically target areas of endothelial catheters [2] and deployment of stents [8] , endothelial cell damage, a feature that is not shared by conventional NO damage and platelet activation still remain a significant donors. problem, highlighting the need for additional therapies Equimolar concentrations of SNVP were compared with which counteract the multiple factors involved in the NTG, because both compounds release 1 molar equivalent response to injury.
of NO [16] . In contrast to NTG, SNVP had minimal effects on systemic blood pressure, but caused a .60% 4 .2. Role of conventional NO donors reduction in platelet adhesion to angioplastied carotid arteries. Both SNVP and NTG inhibited in vitro platelet Delivery of NO is an attractive alternative to convenaggregation in response to ADP, however, only SNVP tional anti-thrombotic agents, because NO exhibits a range inhibited platelet adhesion following angioplasty. Here, of beneficial actions, including vasodilatation, regulation of SNVP was administered as a concentrated bolus immediinflammatory cell function, inhibition of smooth muscle ately upstream of the angioplastied region (Fig. 1) . Our cell mitogenesis and inhibition of platelet activation [24] .
previous results [13] are consistent with the hypothesis that Indeed, NO donors inhibit platelet activation following SNVP is retained in the exposed subendothelial layers, angioplasty [9] [10] [11] 25] . The most common clinically used where it decomposes slowly, generating NO in sufficiently NO donors are the organic nitrates, such as NTG, although high concentrations to inhibit platelet adhesion locally. the selectivity profile of traditional nitrates (veins.
Similar findings with radiolabelled S-nitrosoalbumin have arteries.platelets) is unfavourable. Our results are in been confirmed to be due to adhesion of this agent to the keeping with the recognised selectivity profile of NTG; it area of injury [25] . The inhibitory effect of SNVP on caused a profound systemic hypotension, demonstrating platelet adhesion suggests that this compound might have that vasoactive concentrations of NTG were being used therapeutic potential in the prevention of acute thrombosis that may induce unwanted complications in patients underat the site of angioplasty, possibly from a single adminisgoing angioplasty.
tration, although its impact on long-term complications of NTG is a poor inhibitor of platelet aggregation in vitro interventional procedures remains to be determined.
[26], possibly because PRP lacks the factors necessary for the biotransformation to active NO [27] . In vivo, NTG 4 .4. Study limitations infusion can inhibit platelet activation, presumably via vascular tissue-mediated biotransformation of NTG to NO Damaged vessels lose their hyperactivity to platelets [28] . However, NTG failed to prevent adhesion of radiowithin 8 h after injury, despite incomplete endothelial labelled platelets to the intimal surface of angioplastied regrowth [21, 32] . However, presently it is unknown carotid arteries. These results suggest that bolus NTG can whether the antiplatelet effects of SNVP persist for .30 influence activation of circulating platelets, but its shortmin after angioplasty. In endothelium-denuded rat femoral term effects are not capable of preventing adhesion to the arteries, |75% of the vasodilatation to novel S-nitroexposed subendothelial surface [11] , presumably because sothiols is still present at 4 h [33] , emphasising the long-NTG is not selectively retained in this region. Similarly, acting nature of these compounds. This complementary other drugs, such as aspirin, have also been shown to vasodilator effect would be beneficial in limiting vasoprevent platelet hyper-responsiveness without reducing spasm following angioplasty. However, the results of platelet adhesion [3] .
functional experiments in the current study failed to confirm a prolonged vasodilator effect in rings from 4 .3. Potential of S-nitrosothiols angioplastied carotid arteries treated with SNVP. There 1 was no difference in the maximum contraction to high K S-Nitrosothiols exhibit a number of properties that might Krebs or PE between vessels that received different NO prove advantageous in angioplasty. They show greater donors and no evidence from oxyhemoglobin experiments selectivity for arteries than veins [29] and, unlike organic of NO-mediated, sustained vasodilatation in SNVP-treated nitrates, are also powerful inhibitors of platelet aggregation vessels. However, these results do not preclude the possiboth in vitro [19] and in vivo [12] . S-Nitrosothiols can bility that sufficient S-nitrosothiol remains in the vessel to generate sufficient NO in PRP to inhibit platelet aggregainhibit platelet adhesion, but not to cause vasodilatation. tion [19] . We have previously demonstrated that SNVP Alternatively, the setup time and processing of the isolated causes sustained NO-mediated vasodilatation selectively in carotid ring experiments may reduce the concentrations of blood vessels with damaged endothelium [13] . In addition, drug retained in the tissue. Further experiments are needed
